KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Omega Healthcare Investors (OHI) EBITDA Margin (2016 - 2026)

Omega Healthcare Investors' EBITDA Margin history spans 16 years, with the latest figure at 3149.66% for Q1 2026.

  • On a quarterly basis, EBITDA Margin rose 308937.0% to 3149.66% in Q1 2026 year-over-year; TTM through Mar 2026 was 95.9%, a 3325.0% increase, with the full-year FY2025 number at 70.54%, up 943.0% from a year prior.
  • EBITDA Margin hit 3149.66% in Q1 2026 for Omega Healthcare Investors, up from 69.87% in the prior quarter.
  • Over the last five years, EBITDA Margin for OHI hit a ceiling of 3149.66% in Q1 2026 and a floor of 42.74% in Q1 2023.
  • Historically, EBITDA Margin has averaged 246.12% across 5 years, with a median of 64.37% in 2023.
  • Biggest five-year swings in EBITDA Margin: crashed -230052bps in 2022 and later surged 308937bps in 2026.
  • Tracing OHI's EBITDA Margin over 5 years: stood at 73.51% in 2022, then tumbled by -31bps to 50.67% in 2023, then grew by 23bps to 62.25% in 2024, then grew by 12bps to 69.87% in 2025, then soared by 4408bps to 3149.66% in 2026.
  • Business Quant data shows EBITDA Margin for OHI at 3149.66% in Q1 2026, 69.87% in Q4 2025, and 80.06% in Q3 2025.